Biden says that all 10 drugs targeted for the first Medicare price negotiations will participate

FILE - President Joe Biden speaks about his administration's plans to lower prescription drug costs and protect Social Security and Medicare, Nov. 5, 2022, in Joliet, Ill. The Biden administration says the manufacturers of all of the first 10 prescription drugs it selected for Medicare’s first price negotiations have agreed to participate. Tuesday's announcement clears the way for talks that could lower their costs in coming years and gives the White House a potential political win heading into next year’s presidential election. (AP Photo/Patrick Semansky, File)

WASHINGTON (AP) — President Joe Biden announced Tuesday that the manufacturers of all of the first 10 prescription drugs selected for Medicare's first price negotiations have agreed to participate, clearing the way for talks that could lower their costs in coming years and give him a potential political win heading into next year's election.

include the blood thinner Eliquis, which the White House said was used by more than 3.7 million Medicare enrollees from June of last year through this past May and had an average out-of-pocket cost of $608 per enrollee for 2022. Also included is diabetes treatment Jardiance, which was used by nearly 1.6 million Medicare enrollees and had a 2022 out-of-pocket cost per enrollee of $490.

The ɫtv Press. All rights reserved.

More Health Stories

Sign Up to Newsletters

Get the latest from ɫtvNews in your inbox. Select the emails you're interested in below.